COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Atha Energy Closes Over-Subscribed Bought Deal - Makes Third New Discovery of 2025 Exploration Program at RIB West and Continues to Expand Mineralization at RIB East
ATHA Energy Corp. closes CAD $11.5 Million Over-Subscribed Private Placement. New uranium discoveries at RIB West and RIB East lead to success in Angilak Exploration Program. Geophysics modeling proves successful in identifying mineralization -
-
-
-
COMMUNIQUÉ DE PRESSE
SMX Makes Ghost Plastics Visible and Trackable as Flame-Retardant and Carbon Black Plastics Passport Emerges (NASDAQ:SMX)
SMX and BT-Systems' Competence Center REDWAVE transform recycling from obligation to profit with innovative technology showcased before NAFRA, revolutionizing food, automotive, and electronics markets. Introduction of Plastic Cycle Token (PCT) establishes certified recycled plastics as tradable digital assets -
COMMUNIQUÉ DE PRESSE
Zentek Provides a Preliminary Update on Influenza Countermeasure Candidate Developed Using the Multivalent Aptamer Technology against H1N1 (Seasonal Influenza)
Zentek completes successful in vivo testing of lead influenza aptamer countermeasure for H1N1 as part of ISC Testing Stream, showing promising results for prophylactic treatment and recovery -
COMMUNIQUÉ DE PRESSE
Amdocs Recognized as the #1 Pacesetter in Counterpoint Research's 2025 Entitlement Server Rankings, Highlighting Leadership in eSIM
Amdocs, the market leader in eSIM orchestration, is recognized as the lead Pacesetter in Counterpoint Research's 2025 Global Entitlement Server Rankings. Amdocs' integrated eSIM Cloud platform offers seamless eSIM experience for service providers worldwide -
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies
Telomir Pharmaceuticals announces Telomir-1's new in vitro results inhibiting KDM5 family, expanding epigenetic therapy possibilities in cancer treatment and aging slowdown
